Article Versions Notes

Fernandes R, Ng TL, Alzahrani MJ, Raphael J, Blanchette P, Black M, Stober C, Pond GR, Cella D, Vandermeer L, et al. A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer. Current Oncology. 2023; 30(8):7384-7397. https://doi.org/10.3390/curroncol30080535

Fernandes, Ricardo, Terry L. Ng, Mashari Jemaan Alzahrani, Jacques Raphael, Phillip Blanchette, Morgan Black, Carol Stober, Gregory R. Pond, David Cella, Lisa Vandermeer, and et al. 2023. "A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer" Current Oncology 30, no. 8: 7384-7397. https://doi.org/10.3390/curroncol30080535

Fernandes, R., Ng, T. L., Alzahrani, M. J., Raphael, J., Blanchette, P., Black, M., Stober, C., Pond, G. R., Cella, D., Vandermeer, L., Ibrahim, M., & Clemons, M., on behalf of the REaCT Investigators. (2023). A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer. Current Oncology, 30(8), 7384-7397. https://doi.org/10.3390/curroncol30080535